Everything we know about the new pill against postpartum depression that improves symptoms in just three days
In August, the United States FDA approved Zurzuvae (zuranolone), the first specific oral treatment for postpartum depression, which consists of one pill daily for fourteen days. At the moment, the drug has not yet been approved by the European Medicines Agency (EMA). This is great news, since it is estimated that, worldwide, 17% of new mothers suffer from…